3 Top Biotech ETFs For Q2
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
While owning individual preferred stocks provides more stability, for a “packaged” preferred stock product, consider this actively managed ETF with an attractive 8.6% yield. CLICK… Read More »A Packaged Preferred Stock Product With An Attractive Yield
This stock, just two-and-a-half months old, may be the most wildly undervalued large-cap stock on the market – and it’s expected to soon declare a… Read More »The Most Largely Undervalued Large-Cap Stock
While tech stocks have been on an incredible run, and some are admittedly overvalued, big tech may be about to get even bigger – with… Read More »These Big Tech Names Could Be About To Get A Lot Bigger
As has been on full display in recent weeks, developing an effective vaccine is one thing. Rolling it out efficiently is another. As one tech/industrial… Read More »A Way To Play This Vaccine Rollout Partnership
After experiencing a terrible year due to the pandemic, the outlook for dividends appears much more positive in 2021 – and hedge funds are buying… Read More »Better Times Ahead For Dividends: 10 Blue-Chips Hedge Funds Are Buying
What’s the best way for investors to bet on ongoing economic recovery in 2021? Goldman Sachs has provided its answer: buy stocks from this group.… Read More »These Stocks Will Outperform As The Economy Recovers, According To Goldman Sachs
These three dividend stocks are not household names. But with outstanding track records of dividend growth that are likely to continue, income-seeking investors may want… Read More »Better Know These Unknown Dividend Stocks
Being hated seems to agree with stocks so far this year, as the most hated stocks – i.e. the most heavily shorted stocks – have… Read More »The Upside Of Being Hated
Last year, the popular “Dogs of the Dow” dividend strategy actually worked the opposite of how it’s supposed to, producing a negative 8% total return.… Read More »A Look “Behind The Ears” Of 2021’s Dogs Of The Dow